| Literature DB >> 32272916 |
Woo Kyung Jung1, Sook Shin1, Young Kyung Park1, Suk-Kyung Lim2, Dong-Chan Moon2, Kun Taek Park3, Yong Ho Park4.
Abstract
BACKGROUND: Antimicrobial resistance is becoming increasingly important in both human and veterinary medicine. According to the One Health concept, an important step is to monitor the resistance patterns of pathogenic bacteria. In this study, the antimicrobial susceptibility patterns and trends of bacteria isolated from stray cats, hospital-admitted cats, and veterinary staff in South Korea between 2017 and 2018 were investigated.Entities:
Keywords: Antimicrobial resistance; Cat; Enterobacteriaceae; Enterococcus spp.; Staphylococcus spp.
Year: 2020 PMID: 32272916 PMCID: PMC7147017 DOI: 10.1186/s12917-020-02326-2
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Bacterial isolates from 78 stray cats, 350 hospital-admitted cats, and 294 veterinary staff
| Species identified | Stray cat (78) | Hospital-admitted cat (350) | Veterinary staff (294) | |
|---|---|---|---|---|
| 74 | 264 | 176 | ||
| Coagulase-positive Staphylococci (CPS) | 5 | 29 | 10 | |
| 3 | 5 | 5 | ||
| 2 | 1 | |||
| Coagulase-negative Staphylococci (CNS) | 7 | 4 | ||
| 1 | 2 | |||
| 1 | 1 | 1 | ||
| 2 | 5 | 3 | ||
| 2 | ||||
| 6 | 39 | 89 | ||
| 1 | 8 | 1 | ||
| 29 | 60 | 6 | ||
| 1 | ||||
| 5 | 14 | |||
| 3 | 17 | 4 | ||
| 1 | 5 | |||
| 1 | 1 | 1 | ||
| 6 | 1 | |||
| 14 | 9 | |||
| 3 | 3 | 4 | ||
| 6 | 6 | 1 | ||
| 9 | 26 | 6 | ||
| 1 | 6 | 7 | ||
| 1 | 21 | 3 | ||
| 39 | 189 | 50 | ||
| 1 | 1 | |||
| 1 | 4 | |||
| 4 | 12 | |||
| 2 | ||||
| 1 | 2 | |||
| 1 | ||||
| 1 | ||||
| 2 | ||||
| 1 | ||||
| 31 | 161 | 18 | ||
| 2 | 4 | 2 | ||
| 4 | ||||
| 1 | ||||
| 1 | 17 | |||
| 1 | ||||
| 57 | 149 | 20 | ||
| 3 | 5 | |||
| 2 | 2 | 2 | ||
| 1 | ||||
| 25 | 74 | 9 | ||
| 13 | 38 | 5 | ||
| 4 | 7 | |||
| 10 | 22 | 3 | ||
| 1 | ||||
| Others | 74 | 215 | 45 | |
| Total | 281 | 978 | 570 | |
MICs of 11 antimicrobial agents against 454 Coagulase-negative Staphylococcia isolated in this study
The dilution ranges tested are those contained in the white area. Values above this range indicate MIC values higher than the highest concentration within the range. Values below this range indicate MIC values lower than the lowest concentration within the range. Breakpoints are employed according to VET01S document. When available, susceptible and resistance breakpoints are indicated in vertical dotted and solid lines respectively. For antibiotics without intermediate zone, a single vertical solid line is indicated
MIC50, lowest concentration to inhibit 50% of bacteria; MIC90, lowest concentration to inhibit 90% of bacteria
R Resistant, I Intermediate, S Susceptible, MIC Minimum inhibitory concentration
a64 isolates from stray cats, 230 isolates from hospital-admitted cat, and 160 isolates from hospital staff
bOnly CLSI breakpoint for dog isolates available
cIndicates isolates numbers from stray cat, hospital-admitted cat and hospital staff, respectively
dThe breakpoints derived from human breakpoints used [18]
eNo CLSI breakpoint available
MICs of 11 antimicrobial agents against 60 Coagulase-positive Staphylococcia isolated in this study
The dilution ranges tested are those contained in the white area. Values above this range indicate MIC values higher than the highest concentration within the range. Values below this range indicate MIC values lower than the lowest concentration within the range. Breakpoints are employed according to VET01S document. When available, susceptible and resistance breakpoints are indicated in vertical dotted and solid lines respectively. For antibiotics without intermediate zone, a single vertical solid line is indicated. For oxacillin, breakpoint of S. aureus is indicated in vertical doubled solid line and breakpoint of S. (pseud) intermedius and S. hyicus is in vertical doubled dotted line
MIC50, lowest concentration to inhibit 50% of bacteria; MIC90, lowest concentration to inhibit 90% of bacteria
R Resistant, I Intermediate, S Susceptible, MIC Minimum inhibitory concentration
a10 isolates from stray cats, 34 isolates from hospital-admitted cat, and 16 isolates from hospital staff
bOnly CLSI breakpoint for dog isolates available
cIndicates isolates numbers from stray cat, hospital-admitted cat and hospital staff, respectively
dThe breakpoints derived from human breakpoints used [18]
eNo CLSI breakpoint available
MICs of 13 antimicrobial agents against 278 Enterobacteriaceaea isolated in this study
The dilution ranges tested are those contained in the white area. Values above this range indicate MIC values higher than the highest concentration within the range. Values below this range indicate MIC values lower than the lowest concentration within the range. Breakpoints are employed according to VET01S document. When available, susceptible and resistance breakpoints are indicated in vertical dotted and solid lines respectively
MIC50, lowest concentration to inhibit 50% of bacteria; MIC90, lowest concentration to inhibit 90% of bacteria
R Resistant, I Intermediate, S Susceptible, MIC Minimum inhibitory concentration
a39 isolates from stray cats, 189 isolates from hospital-admitted cat, and 50 isolates from hospital staff
bOnly CLSI breakpoint for dog isolates available
cIndicates isolates numbers from stray cat, hospital-admitted cat, and hospital staff, respectively
dNo CLSI breakpoint available
eThe breakpoints derived from human breakpoints used [18]
fOnly CLSI breakpoint for cattle isolates available
MICs of 10 antimicrobial agents against 226 Enterococcus spp.a isolated in this study
The dilution ranges tested are those contained in the white area. Values above this range indicate MIC values higher than the highest concentration within the range. Values below this range indicate MIC values lower than the lowest concentration within the range. The breakpoints derived from human breakpoints used. When available, susceptible and resistance breakpoints are indicated in vertical dotted and solid lines respectively. For antibiotics without intermediate zone, a single vertical solid line is indicated
MIC50, lowest concentration to inhibit 50% of bacteria; MIC90, lowest concentration to inhibit 90% of bacteria
R Resistant, I Intermediate, S Susceptible, MIC Minimum inhibitory concentration
a57 isolates from stray cats, 149 isolates from hospital-admitted cat, and 20 isolates from hospital staff
bIndicates isolates numbers from stray cat, hospital-admitted cat, and hospital staff, respectively
cHigh-level resistance to streptomycin (2000 μg/ml)
dHigh-level resistance to gentamicin (500 μg/ml)
MICs of 11 antimicrobial agents against 110 mecA-positive staphylococci isolated in this study
| Antimicrobials | stray cats (7) | hospital-admitted cats (32) | veterinary staff (71) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIC50 (μg/ml) | MIC90 (μg/ml) | % R | % I | % S | MIC50 (μg/ml) | MIC90 (μg/ml) | % R | % I | % S | MIC50 (μg/ml) | MIC90 (μg/ml) | % R | % I | % S | |
| Ampicillina | 2 | 32 | 85.7 | 0 | 14.3 | 2 | 32 | 84.4 | 0 | 15.6 | 2 | 16 | 88.7 | 0 | 11.3 |
| Penicillinb | 1 | ≥ 64 | 85.7 | 0 | 14.3 | 2 | 16 | 96.9 | 0 | 3.1 | 2 | 32 | 98.6 | 0 | 1.4 |
| Oxacillinb | 2 | ≥ 64 | 100 | 0 | 0 | 16 | ≥ 64 | 100 | 0 | 0 | 4 | ≥ 64 | 100 | 0 | 0 |
| Amox/clav | 1 | 8 | 57.1 | 28.6 | 14.3 | 1 | 8 | 53.1 | 37.5 | 9.4 | 1 | 4 | 66.2 | 19.7 | 14.1 |
| Cephalexinc | 16 | 64 | 16 | 64 | 16 | 64 | |||||||||
| Gentamicinb | 0.25 | 32 | 28.6 | 0 | 71.4 | 8 | ≥ 64 | 40.6 | 18.8 | 40.6 | 32 | ≥ 64 | 60.6 | 5.6 | 33.8 |
| Clindamycina | 0.5 | 16 | 14.3 | 28.6 | 57.1 | 0.12 | 4 | 12.5 | 0 | 87.5 | 0.12 | 8 | 15.5 | 5.6 | 78.9 |
| Enrofloxacin | 0.25 | 2 | 0 | 14.3 | 85.7 | 0.25 | 4 | 12.5 | 15.6 | 71.9 | 0.5 | 16 | 14.1 | 32.4 | 53.5 |
| Marbofloxacin | 0.25 | 2 | 0 | 14.3 | 85.7 | 0.5 | 16 | 12.5 | 0 | 87.5 | 0.5 | 8 | 14.1 | 5.6 | 80.3 |
| Chloramphenicolb | 4 | 32 | 14.3 | 0 | 85.7 | 4 | 8 | 3.1 | 0 | 96.9 | 4 | 8 | 2.8 | 1.4 | 95.8 |
| Tetracyclinea | 32 | 64 | 57.1 | 28.6 | 14.3 | 1 | 64 | 53.1 | 25 | 21.9 | 64 | ≥ 128 | 88.7 | 5.6 | 5.6 |
Breakpoints are employed according to VET01S document
MIC50, lowest concentration to inhibit 50% of bacteria; MIC90, lowest concentration to inhibit 90% of bacteria
R Resistant, I Intermediate, S Susceptible, MIC Minimum inhibitory concentration
aOnly CLSI breakpoint for dog isolates available
bThe breakpoints derived from human breakpoints used [18]
cNo CLSI breakpoint available
The most prevalent resistance profile per antimicrobial category found in Coagulase-negative Staphylococci isolated in this study based on CLSI human clinical breakpoint data
| No. antimicrobial category | No. of isolates (%) | Resistance pattern (no. of isolates) | ||
|---|---|---|---|---|
| stray cats ( | hospital-admitted cats ( | veterinary staff ( | ||
| All susceptible | 115 (25.3) | 31 | 64 | 20 |
| 1 | 109 (24.0) | OXA (11) | BLA (37) | BLA (18) |
| 2 | 80 (17.6) | BLA-OXA (4) | BLA-OXA (38) | BLA-OXA (15) |
| 3 | 54 (11.9) | AMG-BLA-OXA (1) | BLA-BLI-OXA (14) | BLA-BLI-OXA (9) |
| 4 | 38 (8.4) | BLA-BLI-OXA-TET (2) | AMG-BLA-OXA-TET (3) | AMG-BLA-OXA-TET (8) |
| 5 | 39 (8.6) | – | AMG-BLA-BLI-OXA-TET (4) | AMG-BLA-BLI-OXA-TET (24) |
| 6 | 18 (4.0) | AMG-BLA-BLI-OXA-LIN-TET (1) | AMG-BLA-BLI-OXA-FQN-TET (2) | AMG-BLA-BLI-OXA-FQN-TET (6) |
| 7 | 3 (0.7) | – | AMG-BLA-BLI-OXA-LIN-PNC-TET (2) | AMG-BLA-BLI-OXA-FQN-LIN-TET (2) |
| Non-MDR | 304 (67.0) | 57 (89.1a) | 179 (77.8a) | 68 (42.5a) |
| MDR | 150 (33.0) | 7 (10.9a) | 51 (22.2a) | 92 (57.5a) |
Antimicrobial categories included: aminoglycosides, AMG (gentamicin); β-lactam groups, BLA (ampicillin and penicillin); Oxacillin, OXA; β-lactam/β-lactamase inhibitor combination, BLI (amoxicillin/clavulanate); fluoroquinolones, FQN (enrofloxacin and marbofloxacin); lincosamide, LIN (clindamycin); phenicol, PNC (chloramphenicol); and tetracycline, TET
aPercentages
The most prevalent resistance profile per antimicrobial category found in Enterobacteriaceae isolated in this study based on CLSI human clinical breakpoint data
| No. antimicrobial category | No. of isolates (%) | Resistance pattern (no. of isolates) | ||
|---|---|---|---|---|
| stray cats ( | hospital-admitted cats ( | veterinary staff ( | ||
| All susceptible | 135 (48.6) | 29 | 99 | 7 |
| 1 | 32 (11.5) | BLA (2) | BLA (9) | BLA (3) |
| 2 | 40 (14.4) | BLA-BLI (1) | BLA-TET (8) | GC-TET (9) |
| 3 | 48 (17.3) | BLA-BLI-GC (1) | BLA-BLI-GC (11) | BLA-BLI-GC (9) |
| 4 | 12 (4.3) | BLA-BLI-GC-CPM (1) | BLA-BLI-GC-3GC (3) | AMG-BLA-BLI-TET (1) |
| 5 | 9 (3.2) | BLA-BLI-GC-3GC-TET (1) | BLA-BLI-GC-3GC-TET (4) | – |
| 6 | 2 (0.7) | – | AMG-BLA- GC-3GC-FQN-TET (1) | – |
| Non-MDR | 207 (74.5) | 35 (89.7a) | 144 (76.2a) | 28 (56.0a) |
| MDR | 71 (25.5) | 4 (10.3a) | 45 (23.8a) | 22 (44.0a) |
Antimicrobial categories included: aminoglycosides, AMG (gentamicin); β-lactam group, BLA (ampicillin); β-lactam/β-lactamase inhibitor combination, BLI (amoxicillin/clavulanate); 1st and 2nd generation cephalosporins, GC (cephalexin, cephalothin and cefoxitin); 3rd generation cephalosporins, 3GC (ceftiofur and ceftriaxone); fluoroquinolones, FQN (enrofloxacin and marbofloxacin); carbapenems, CPM (imipenem and meropenem); and tetracycline, TET
aPercentages
The most prevalent resistance profile per antimicrobial category found in Enterococcus spp. isolated in this study based on CLSI human clinical breakpoint data
| No. antimicrobial category | No. of isolates (%) | Resistance pattern (no. of isolates) | ||
|---|---|---|---|---|
| stray cats ( | hospital-admitted cats ( | veterinary staff ( | ||
| All susceptible | 63 (27.9) | 13 | 43 | 7 |
| 1 | 50 (22.1) | TET (8) | TET (23) | TET (6) |
| 2 | 47 (20.8) | MAC-TET (10) | MAC-TET (16) | MAC-TET (3) |
| 3 | 31 (13.7) | MAC-PNC-TET (5) | MAC-PNC-TET (8) | – |
| 4 | 14 (6.2) | STM-MAC-PNC-TET (2) | AMG-MAC-PNC-TET (4) | AMG-MAC-PNC-TET (1) |
| 5 | 12 (5.3) | AMG-BLA-FQN-MAC-TET (2) | AMG-BLA-FQN-MAC-TET (7) | – |
| 6 | 6 (2.6) | AMG-STM-BLA-FQN-MAC-TET (2) | AMG-STM-BLA-FQN-MAC-TET (2) | – |
| 7 | 3 | – | AMG-STM-BLA-FQN-MAC-PNC-TET (3) | – |
| Non-MDR | 160 (70.8) | 39 (68.4a) | 102 (68.5a) | 19 (95.0a) |
| MDR | 66 (29.2) | 18 (31.6a) | 47 (31.5a) | 1 (5.0a) |
Antimicrobial categories included: aminoglycosides except streptomycin, AMG (gentamicin); streptomycin, STM; β-lactam groups, BLA (ampicillin and penicillin); glycopeptide, GLP (vancomycin); fluoroquinolone, FQN (ciprofloxacin); macrolide, MAC (erythromycin); phenicol, PNC (chloramphenicol); and tetracycline, TET
aPercentages
Fig. 1Geographical distribution of veterinary hospitals included on this study. The map shows physical locations of veterinary hospitals in which samples collected (closed circles) and the number of samples collected in each province. The number in parentheses indicates the total of swap samples collected from the indicated number of individual cats or staffs. SC, Stray cats; HAC, hospitals-admitted cats; VS, veterinary staffs. The map used in the figure was taken from the National Geographic Information Institute of Korea (https://www.ngii.go.kr/child/contend.do?sq=149)